Both in Pharmaceuticals
Dare Bioscience vs Lipocine
Over the past year DARE returned −64.9% and LPCN returned −45.7%; their daily moves had a correlation of 0.10.
DARE −64.9% LPCN −45.7%Growth of $1, one year, split-adjusted
| Metric | DARE | LPCN |
|---|---|---|
| Price | $0.6736 | $1.44 |
| Market cap | $13.2M | $11.9M |
| Today | −3.72% | 0.00% |
| 1 month | −20.1% | −29.8% |
| 6 months | −78.3% | −37.1% |
| Year to date | −65.1% | −82.1% |
| 1 year | −65.1% | −44.6% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | −70.6% | — |
| Net margin | −1590.4% | — |
| P/E (TTM) | — | — |
| Price / sales | 9.7× | 9.4× |
| Net cash | $12.5M | $23.3M |
| Dividend yield | — | — |
| Volatility (60d) | 99.1% | 57.4% |
| Short % of float | 6.2% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).